Hoth Therapeutics director Vadim Mats resigns from Board effective Jan 31, 2022

Hoth Therapeutics, Inc.

Director Vadim Mats informed the Company he will resign from the Board and its compensation and nominating/corporate governance committees.
Resignation effective January 31, 2022; not due to any disagreement with the Company's operations, policies, management, or Board.
No replacement has been announced; Board size will decrease by one member.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Vadim Mats

Director

HOTH · Hoth Therapeutics, Inc.

Effective: 2022-01-31
Filed: January 21, 2022, 6:59 PM ET

On January 19, 2022, Vadim Mats informed Hoth Therapeutics, Inc. (the “Company”) that he will be resigning from the Company’s Board of Directors (the “Board”) as well as the Company’s compensation committee and nominating and corporate governance committee effective as of January 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Vadim Mats departed as Director at Hoth Therapeutics, Inc..

Action: resigning
Role: Director

Exact text from the filing

On January 19, 2022, Vadim Mats informed Hoth Therapeutics, Inc. (the “Company”) that he will be resigning from the Company’s Board of Directors (the “Board”) as well as the Company’s compensation committee and nominating and corporate governance committee effective as of January 31, 2022.

View on SEC.gov

Hoth Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-003061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.